Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights challenges like revenue decline, high client churn, and financial stress in mature markets, despite minor sequential growth. The voluntary NASDAQ delisting and increased provisions for credit losses raise concerns about financial stability and investor confidence. Although strategic investments and new market expansions are positive, the overall sentiment is negative due to persistent risks and uncertainties in the cannabis industry.
Revenue $43.6 million, down 2% year-over-year and up 1% sequentially. Sequential growth was driven by increased client spend in March ahead of the 4/20 holiday. The year-over-year decline was attributed to price compression, elevated tax burdens, and broader financial stress in mature markets like California, Michigan, and Colorado.
Average Monthly Paying Clients Approximately 4,983, down 4% year-over-year and 3% sequentially. The decline was primarily due to churn in mature markets caused by financial pressures leading to business closures and account removals related to nonpayment. This was partially offset by new client acquisitions in newer markets like New York and Mississippi.
Average Revenue Per Paying Client $2,914, a marginal increase compared to the first quarter of last year. The increase was due to churn among lower-spend clients, which had a favorable mix impact on the average.
Operating Expenses $43.4 million, compared to $42 million in the first quarter of last year. The increase was primarily driven by a higher provision for credit losses, including a $3.9 million allowance for doubtful accounts due to ongoing financial pressure on operators. This was partially offset by lower costs in other areas, including headcount, vendor spend, and discretionary expenses.
Net Income $1.7 million. This included nonrecurring costs such as restructuring expenses, partially offset by a $1 million gain from the sale of a domain name.
Adjusted EBITDA $5.9 million, excluding nonrecurring costs and other adjustments.
Net Cash Used in Operating Activities $1.3 million, primarily reflecting slower collections to start the year and the timing of working capital.
Cash and Investments $57 million, consisting primarily of cash, short-term treasuries, and bonds as of March 31, 2026.
Development and expansion of technology platform and services: The company plans to expand its technology platform and services into areas previously restricted by Nasdaq, aiming to better serve the cannabis ecosystem.
Newer market growth: Growth in newer markets such as New York and Mississippi partially offset client churn in mature markets.
Revenue performance: Revenue for Q1 2026 was $43.6 million, down 2% year-over-year but up 1% sequentially, driven by increased client spend in March.
Client churn and retention: Average monthly paying clients decreased by 4% year-over-year and 3% sequentially, primarily due to churn in mature markets like California, Michigan, and Colorado.
Cost management: Operating expenses increased to $43.4 million due to higher provisions for credit losses, but the company managed headcount, vendor spend, and discretionary expenses to maintain flexibility.
Voluntary delisting from Nasdaq: The company delisted from Nasdaq to gain flexibility in pursuing opportunities across the cannabis ecosystem and align with industry realities.
Strategic investments: Plans to invest in strategic clients and partner companies across the cannabis supply chain to enhance the Weedmaps ecosystem.
Federal Rescheduling of Cannabis: Uncertainty around the implementation and benefits of the federal rescheduling of medical cannabis to Schedule III, including its impact on operators and the broader cannabis industry.
Operating Environment for Cannabis Businesses: Challenges include price compression due to oversupply and competition, pressure on consumer discretionary spending, elevated tax burdens, limited access to capital, and regulatory uncertainty at both federal and state levels.
Client Budgets and Business Stability: Client budgets and business stability are under pressure, impacting their ability to invest for growth and affecting the company's revenue.
Client Retention and Churn: High churn rates in mature markets like California, Michigan, and Colorado due to financial pressures, business closures, and nonpayment issues.
Accounts Receivable Management: Increased provision for credit losses and challenges in collecting payments from delinquent accounts, leading to a $3.9 million allowance for doubtful accounts.
Revenue Decline in Mature Markets: Revenue is negatively impacted by financial stress in mature markets, with a sequential decline in client numbers and spending.
NASDAQ Delisting: The voluntary delisting from NASDAQ limits the company's visibility and may impact investor confidence, despite providing strategic flexibility.
Voluntary delisting from NASDAQ: The company has voluntarily delisted from NASDAQ to gain greater flexibility in pursuing opportunities across the cannabis ecosystem. This move allows the company to invest in strategic clients and partner companies across the cannabis supply chain and expand its technology platform and services into areas previously restricted by NASDAQ policies.
Platform and ecosystem expansion: The company plans to build a platform that better serves the cannabis ecosystem, including retailers, brands, MSOs, and consumers. This includes improving the core marketplace and investing in new products and capabilities aligned with industry trends.
Revenue outlook for Q2 2026: The company expects second-quarter revenue to decline sequentially by low single digits from the first quarter, reflecting continued client churn and account removals in mature markets, as well as normalized client spending post the 4/20 holiday.
Investment priorities: The company will focus on managing costs while selectively investing in key areas of the business to support long-term priorities.
The selected topic was not discussed during the call.
The earnings call highlights challenges like revenue decline, high client churn, and financial stress in mature markets, despite minor sequential growth. The voluntary NASDAQ delisting and increased provisions for credit losses raise concerns about financial stability and investor confidence. Although strategic investments and new market expansions are positive, the overall sentiment is negative due to persistent risks and uncertainties in the cannabis industry.
The earnings call reveals declining revenues and client challenges due to market consolidation and industry pressures. Despite some positive aspects like strong liquidity management, the overall sentiment is negative due to revenue declines, legal and financial liabilities, and the impact of industry dynamics. The Q&A section didn't provide additional positive insights to alter this sentiment. Without a market cap, the exact impact is unclear, but the negative factors outweigh the positives, leading to a likely stock price decline in the range of -2% to -8%.
The earnings call highlights revenue decline, price compression, and regulatory challenges, which are significant concerns. While the company maintains profitability and cash reserves, the negative trends in core markets and client churn overshadow the positives. The lack of clear guidance and the focus on long-term prospects at the expense of near-term revenue add to the uncertainty, suggesting a negative market reaction.
The earnings call summary presents mixed signals. While there is modest revenue growth and positive cash generation, regulatory challenges and declining client spending pose risks. The Q2 guidance shows stability but lacks significant upside. Product development and client base growth are positive, but operational challenges and market pressures could offset gains. Without a strong catalyst or significant market cap details, the stock price is likely to remain stable in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.